Suchergebnisse - "Halpin, David M G"

PubPharm (33)

1

A Response to : Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"

enthalten in: Advances in therapy | 2023

von Ismaila, A. | Haeussler, K. | Malmenäs, M. | +5

CommentOn: Adv Ther. 2022 Sep;39(9):3957-3978. - PMID 35849317

2

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease : Post hoc analysis of the IMPACT trial

enthalten in: Respirology (Carlton, Vic.) | 2022

von Thompson, P. | Criner, G. | Dransfield, M. | +9

CommentIn: Respirology. 2022 Dec;27(12):1006-1007. - PMID 36031687

3

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD : IMPACT trial post hoc analysis

enthalten in: Respiratory medicine | 2022

von Bardsley, S. | Criner, G. | Halpin, D. | +12

4

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease : A Network Meta-Analysis

enthalten in: Advances in therapy | 2022

von Ismaila, A. | Haeussler, K. | Czira, A. | +11

ErratumIn: Adv Ther. 2022 Sep 2;:. - PMID 36056291

5

Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline

enthalten in: Respiratory medicine | 2022

von Bourdin, A. | Virchow, J. | Papi, A. | +11

6

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries : a systematic review

enthalten in: The Lancet. Global health | 2022

von Stolbrink, M. | Thomson, H. | Hadfield, R. | +9

CommentIn: Lancet Glob Health. 2022 Oct;10(10):e1365-e1366. - PMID 36113511

7

Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease : Post Hoc Analysis From the IMPACT Trial

enthalten in: Journal of the American Heart Association | 2022

von Dransfield, M. | Criner, G. | Halpin, D. | +10

CommentIn: J Am Heart Assoc. 2022 Sep 20;11(18):e027112. - PMID 36102223

8

Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD : A Network Meta-Analysis

enthalten in: Advances in therapy | 2022

von Ismaila, A. | Haeussler, K. | Czira, A. | +10

CommentIn: Adv Ther. 2023 May;40(5):2549-2555. - PMID 37004641

9

Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Domingo, C. | Maspero, J. | Castro, M. | +12

10

Blood Eosinophils and Chronic Obstructive Pulmonary Disease : A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review

enthalten in: American journal of respiratory and critical care medicine | 2022

von Singh, D. | Agusti, A. | Martinez, F. | +5